melatonin has been researched along with alpha-synuclein in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Ishido, M | 1 |
| Chao, PL; Fang, SF; Lin, AM; Yang, CH | 1 |
| Ebadi, M; Govitrapong, P; Klongpanichapak, S; Phansuwan-Pujito, P | 1 |
| Caballero, B; Camins, A; Coto-Montes, A; De Gonzalo-Calvo, D; Gutierrez-Cuesta, J; Huidobro-Fernández, C; Pallas, M; Rodríguez-Colunga, MJ; Sierra, V; Soria-Valles, C; Tolivia, D; Vega-Naredo, I | 1 |
| Govitrapong, P; Mukda, S; Vimolratana, O | 1 |
| Govitrapong, P; Phansuwan-Pujito, P; Sae-Ung, K; Uéda, K | 1 |
| Ikeda, T; Mochizuki, H; Nihira, T; Ono, K; Takasaki, J; Teplow, DB; Yamada, M | 1 |
| Chang, CF; Huang, HJ; Hung, KC; Lee, HC; Lin, AM; Wu, RT | 1 |
| Baekelandt, V; Brito-Armas, JM; Castro, R; Castro-Hernández, JR; González-Hernández, T; Rodríguez, M | 1 |
| Phillipson, OT | 1 |
| Huang, HJ; Lin, AM; Tai, YI; Teng, YC | 1 |
| Feng, YM; Hu, XT; Lei, XG; Li, GD; Li, H; Li, JL; Luo, R; Lv, L; Ma, L; Su, LY; Xu, L; Yao, YG; Zhou, HJ | 1 |
| Guo, S; Guo, X; Han, C; Huang, J; Lin, Z; Liu, L; Ma, K; Shen, Y; Wan, F; Wang, L; Wang, T; Xia, Y; Xiong, N | 1 |
| Barros, MH; Zampol, MA | 1 |
| Kovalzon, VM; Ukraintseva, YV | 1 |
| Boeve, B; Dauvilliers, Y; Iranzo, A; Luppi, PH; Montplaisir, J; Plazzi, G; Postuma, RB; Schenck, CH | 1 |
| Cerezo, AB; Gallardo-Fernández, M; García-Parrilla, MC; Hornedo-Ortega, R; Troncoso, AM | 1 |
| Choudhury, SR; Karmakar, S; Srivastava, AK | 1 |
| Amran, MS; Ashraf, GM; Behl, T; Jeandet, P; Rauf, A; Sumsuzzman, DM; Uddin, MS | 1 |
4 review(s) available for melatonin and alpha-synuclein
| Article | Year |
|---|---|
Management of the aging risk factor for Parkinson's disease.
Topics: Acetylcarnitine; Adenosine Triphosphate; Aging; alpha-Synuclein; Antioxidant Response Elements; Carbohydrate Metabolism; Electron Transport; Energy Metabolism; Fatty Acids; Glial Cell Line-Derived Neurotrophic Factor; Humans; Inflammation; Melatonin; Mitochondria; Nitric Oxide; Oxidative Stress; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proteostasis Deficiencies; Risk Factors; Thioctic Acid; Transcription Factors; Ubiquinone | 2014 |
The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Circadian Clocks; Dopamine; Dopaminergic Neurons; Genetic Predisposition to Disease; Humans; Hypothalamus; Inflammation; Melatonin; Nerve Degeneration; Parkinson Disease; Receptors, Cytoplasmic and Nuclear; Receptors, Dopamine; Weight Loss | 2017 |
REM sleep behaviour disorder.
Topics: alpha-Synuclein; Antidepressive Agents; Central Nervous System Depressants; Clonazepam; Diagnosis, Differential; Humans; Mass Screening; Melatonin; Parkinson Disease; Polysomnography; Prevalence; REM Sleep Behavior Disorder; Risk Factors; Sex Factors | 2018 |
Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Animals; Circadian Rhythm; Gastrointestinal Microbiome; Humans; Melatonin; Sleep; Sleep Disorders, Circadian Rhythm; tau Proteins | 2021 |
15 other study(ies) available for melatonin and alpha-synuclein
| Article | Year |
|---|---|
Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; alpha-Synuclein; Animals; Fungicides, Industrial; Maneb; Melatonin; PC12 Cells; Pheochromocytoma; Rats | 2007 |
Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein.
Topics: alpha-Synuclein; Animals; Apoptosis; Arsenites; Brain; Endoplasmic Reticulum; HSP70 Heat-Shock Proteins; Male; Melatonin; Mitochondria; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2007 |
Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
Topics: alpha-Synuclein; Amphetamine; Antioxidants; Cell Line, Tumor; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Electron Transport Complex I; Gene Expression Regulation, Neoplastic; Humans; Melatonin; Neuroblastoma; Phosphorylation; Serine; Tyrosine 3-Monooxygenase | 2008 |
Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice.
Topics: Aging; Aging, Premature; alpha-Synuclein; Animals; Antioxidants; Brain; Lewy Bodies; Melatonin; Mice; Nerve Degeneration; Neurofibrillary Tangles; NF-kappa B p50 Subunit; Nuclear Receptor Subfamily 1, Group F, Member 1; Oxidative Stress; Protein Carbonylation; Receptor, Melatonin, MT1; Receptors, Cytoplasmic and Nuclear; Signal Transduction; tau Proteins; Trans-Activators | 2008 |
Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum.
Topics: alpha-Synuclein; Amphetamine; Animals; Animals, Newborn; Blotting, Western; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Melatonin; Phosphorylation; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2011 |
Melatonin reduces the expression of alpha-synuclein in the dopamine containing neuronal regions of amphetamine-treated postnatal rats.
Topics: alpha-Synuclein; Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Brain; Dopamine; Melatonin; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar | 2012 |
Effect of melatonin on α-synuclein self-assembly and cytotoxicity.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Antioxidants; Antiparkinson Agents; Benzothiazoles; Brain; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Melatonin; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Neurons; Protein Structure, Secondary; Sincalide; Thiazoles; Time Factors; Trihexyphenidyl | 2012 |
Melatonin attenuates kainic acid-induced neurotoxicity in mouse hippocampus via inhibition of autophagy and α-synuclein aggregation.
Topics: alpha-Synuclein; Animals; Autophagy; Base Sequence; Hippocampus; Immunoprecipitation; Kainic Acid; Melatonin; Mice; RNA, Small Interfering | 2012 |
Melatonin prevents dopaminergic cell loss induced by lentiviral vectors expressing A30P mutant alpha-synuclein.
Topics: alpha-Synuclein; Animals; Antioxidants; DNA, Complementary; Dopamine; Genetic Vectors; Green Fluorescent Proteins; Humans; Immunohistochemistry; Lentivirus; Male; Melatonin; Mutation; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Substantia Nigra | 2013 |
Melatonin Ameliorates Arsenite-Induced Neurotoxicity: Involvement of Autophagy and Mitochondria.
Topics: Adenine; alpha-Synuclein; Animals; Antioxidants; Arsenites; Autophagy; Biomarkers; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Electron Transport Complex IV; Female; Lysosomes; Melatonin; Mitochondria; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pregnancy; Rats; Rats, Sprague-Dawley; Sodium Compounds; Transcription Factors | 2015 |
Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Autophagy; Cyclin-Dependent Kinase 5; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Haplorhini; Melatonin; Mice; Neurotoxins; Parkinson Disease | 2015 |
Melatonin improves survival and respiratory activity of yeast cells challenged by alpha-synuclein and menadione.
Topics: alpha-Synuclein; Cell Survival; Electron Transport Complex IV; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Melatonin; Oxygen Consumption; Saccharomyces cerevisiae; Vitamin K 3 | 2018 |
[Circadian Regulation and Its Disorders in Parkinson's Disease Patients. Part 2. Experimental Models, Alpha-Synuclein and Melatonin.]
Topics: alpha-Synuclein; Circadian Rhythm; Dopamine; Humans; Melatonin; Parkinson Disease; Suprachiasmatic Nucleus | 2016 |
Melatonin, protocatechuic acid and hydroxytyrosol effects on vitagenes system against alpha-synuclein toxicity.
Topics: alpha-Synuclein; Animals; Heme Oxygenase (Decyclizing); HSP70 Heat-Shock Proteins; Hydroxybenzoates; Melatonin; Neuroprotective Agents; PC12 Cells; Phenylethyl Alcohol; Rats; Sirtuin 2 | 2019 |
Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of α-synuclein in experimental Parkinson's disease models.
Topics: alpha-Synuclein; Animals; Brain; Cell Line, Tumor; Female; Humans; Melatonin; Mice; Mice, Inbred BALB C; Models, Animal; Neuroprotection; Parkinson Disease; Phosphorylation; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Proteasome Endopeptidase Complex; Rats; Rotenone; Ubiquitination | 2021 |